Discover B2B companies, suppliers, and manufacturers related to this keyword category
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Navigating the Middle East & Africa to Broaden Patient Access, Faster
Your Leader in Rare Disease and Complex Therapy Programs
brought to you by Informa Connect
Science fiction becoming science fact.
Personalized T-cell therapies for hematologic malignancies and solid tumors.
Cellectis is developing life-changing product candidates to target and eradicate cancer cells.
Inspired by Nature, driven by data, built for humanity.
Akimbo Bio is developing dual CAR/TCR therapies intended for in vivo delivery via lentiviral vectors.
Your Bridge from ATMPs Concept to Commercialization
Australia & New Zealand's only not-for-profit collaborative blood cancer research group
We're on a mission to make regenerative medicine a part of everyday medicine.
Market Access Today: Your go-to source for the latest insights, trends, and updates in Market Acces, HEOR, HTA, and RWE.
Redefining cell therapy manufacturing for the allogeneic future.
Enabling life-saving therapies with a unique technology for cell engineering
Your Leader in Rare Disease and Complex Therapy Programs